476 related articles for article (PubMed ID: 16036790)
1. Human immunodeficiency virus type 1 genetic diversity in the nervous system: evolutionary epiphenomenon or disease determinant?
van Marle G; Power C
J Neurovirol; 2005 Apr; 11(2):107-28. PubMed ID: 16036790
[TBL] [Abstract][Full Text] [Related]
2. Comparative neurovirulence in lentiviral infections: The roles of viral molecular diversity and select proteases.
Power C; Zhang K; van Marle G
J Neurovirol; 2004; 10 Suppl 1():113-7. PubMed ID: 14982749
[TBL] [Abstract][Full Text] [Related]
3. Study of the impact of HIV genotypic drug resistance testing on therapy efficacy.
Van Vaerenbergh K
Verh K Acad Geneeskd Belg; 2001; 63(5):447-73. PubMed ID: 11813503
[TBL] [Abstract][Full Text] [Related]
4. HIV-1 compartmentalization in diverse leukocyte populations during antiretroviral therapy.
Potter SJ; Lemey P; Achaz G; Chew CB; Vandamme AM; Dwyer DE; Saksena NK
J Leukoc Biol; 2004 Sep; 76(3):562-70. PubMed ID: 15218056
[TBL] [Abstract][Full Text] [Related]
5. Extensive recombination among human immunodeficiency virus type 1 quasispecies makes an important contribution to viral diversity in individual patients.
Charpentier C; Nora T; Tenaillon O; Clavel F; Hance AJ
J Virol; 2006 Mar; 80(5):2472-82. PubMed ID: 16474154
[TBL] [Abstract][Full Text] [Related]
6. Progress in clinical neurosciences: The neuropathogenesis of HIV infection: host-virus interaction and the impact of therapy.
Power C; Gill MJ; Johnson RT
Can J Neurol Sci; 2002 Feb; 29(1):19-32. PubMed ID: 11858531
[TBL] [Abstract][Full Text] [Related]
7. Combating the HIV reservoirs.
van Marle G; Church DL; van der Meer F; Gill MJ
Biotechnol Genet Eng Rev; 2018 Apr; 34(1):76-89. PubMed ID: 29781356
[TBL] [Abstract][Full Text] [Related]
8. Human immunodeficiency virus and the brain.
Glass JD; Johnson RT
Annu Rev Neurosci; 1996; 19():1-26. PubMed ID: 8833434
[TBL] [Abstract][Full Text] [Related]
9. Brain-derived human immunodeficiency virus-1 Tat exerts differential effects on LTR transactivation and neuroimmune activation.
Boven LA; Noorbakhsh F; Bouma G; van der Zee R; Vargas DL; Pardo C; McArthur JC; Nottet HS; Power C
J Neurovirol; 2007 Apr; 13(2):173-84. PubMed ID: 17505986
[TBL] [Abstract][Full Text] [Related]
10. [Evolution and Diversity of HIV-1].
Metzner KJ
Praxis (Bern 1994); 2011 Jan; 100(1):29-35. PubMed ID: 21210358
[TBL] [Abstract][Full Text] [Related]
11. Independent evolution of human immunodeficiency virus (HIV) drug resistance mutations in diverse areas of the brain in HIV-infected patients, with and without dementia, on antiretroviral treatment.
Smit TK; Brew BJ; Tourtellotte W; Morgello S; Gelman BB; Saksena NK
J Virol; 2004 Sep; 78(18):10133-48. PubMed ID: 15331746
[TBL] [Abstract][Full Text] [Related]
12. HIV-1 reverse transcriptase inhibitor resistance mutations and fitness: a view from the clinic and ex vivo.
Martinez-Picado J; Martínez MA
Virus Res; 2008 Jun; 134(1-2):104-23. PubMed ID: 18289713
[TBL] [Abstract][Full Text] [Related]
13. Genetic Consequences of Antiviral Therapy on HIV-1.
Arenas M
Comput Math Methods Med; 2015; 2015():395826. PubMed ID: 26170895
[TBL] [Abstract][Full Text] [Related]
14. The HIV-1 associated dementia complex: a metabolic encephalopathy fueled by viral replication in mononuclear phagocytes.
Zheng J; Gendelman HE
Curr Opin Neurol; 1997 Aug; 10(4):319-25. PubMed ID: 9266156
[TBL] [Abstract][Full Text] [Related]
15. Cellular & molecular basis of HIV-associated neuropathogenesis.
Sharma D; Bhattacharya J
Indian J Med Res; 2009 Jun; 129(6):637-51. PubMed ID: 19692743
[TBL] [Abstract][Full Text] [Related]
16. The effects of human immunodeficiency virus in the central nervous system.
Kolson DL; Lavi E; González-Scarano F
Adv Virus Res; 1998; 50():1-47. PubMed ID: 9520995
[TBL] [Abstract][Full Text] [Related]
17. The interaction of HIV-1 with the host factors.
Komano J; Futahashi Y; Urano E; Miyauchi K; Murakami T; Matsuda Z; Yamamoto N
Jpn J Infect Dis; 2005 Jun; 58(3):125-30. PubMed ID: 15973003
[TBL] [Abstract][Full Text] [Related]
18. Could differential virological characteristics account for ongoing viral replication and insidious damage of the brain during HIV 1 infection of the central nervous system?
Vissers M; Stelma FF; Koopmans PP
J Clin Virol; 2010 Dec; 49(4):231-8. PubMed ID: 20833583
[TBL] [Abstract][Full Text] [Related]
19. CRF19_cpx is an Evolutionary fit HIV-1 Variant Strongly Associated With Rapid Progression to AIDS in Cuba.
Kouri V; Khouri R; Alemán Y; Abrahantes Y; Vercauteren J; Pineda-Peña AC; Theys K; Megens S; Moutschen M; Pfeifer N; Van Weyenbergh J; Pérez AB; Pérez J; Pérez L; Van Laethem K; Vandamme AM
EBioMedicine; 2015 Mar; 2(3):244-54. PubMed ID: 26137563
[TBL] [Abstract][Full Text] [Related]
20. Molecular biological assessment methods and understanding the course of the HIV infection.
Katzenstein TL
APMIS Suppl; 2003; (114):1-37. PubMed ID: 14626050
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
